Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: Barbarich et al.1 report the potential benefits of olanzapinein treating anorexia nervosa. I disagree with their resultsand conclusions for the following reasons.The study’s small sample size of 17 patients, 12 of whomcompleted the study, could result in a type II error. That 71% ofpatients completed the study is not "noteworthy," as the authorsclaim’ ‹
Save
Cite
Advertisement
GAM ID: sidebar-top